MedPath

Somerset Therapeutics, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

41

FDA:41

Drug Approvals

Nalbuphine hydrochloride

Approval Date
Mar 26, 2025
FDA

CALCIUM GLUCONATE

Approval Date
Mar 27, 2024
FDA

VALGANCICLOVIR HYDROCHLORIDE

Approval Date
Jan 30, 2024
FDA

cyanocobalamin

Approval Date
Dec 20, 2023
FDA

Dexamethasone Sodium Phosphate

Approval Date
Dec 20, 2023
FDA

Naloxone Hydrochloride

Approval Date
Dec 19, 2023
FDA

Methocarbamol

Approval Date
Dec 18, 2023
FDA

DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE

Approval Date
Dec 18, 2023
FDA

Naloxone Hydrochloride

Approval Date
Dec 18, 2023
FDA

HALOPERIDOL DECANOATE

Approval Date
Dec 18, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy